SOLAVAX Trademark

Trademark Overview

On Tuesday, March 24, 2020, a trademark application was filed for SOLAVAX with the United States Patent and Trademark Office. The USPTO has given the SOLAVAX trademark a serial number of 88846226. The federal status of this trademark filing is REGISTERED as of Tuesday, November 1, 2022. This trademark is owned by Colorado State University Research Foundation. The SOLAVAX trademark is filed in the Pharmaceutical Products category with the following description:

vaccines
solavax

General Information

Serial Number88846226
Word MarkSOLAVAX
Filing DateTuesday, March 24, 2020
Status700 - REGISTERED
Status DateTuesday, November 1, 2022
Registration Number6890077
Registration DateTuesday, November 1, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2020

Trademark Statements

Goods and Servicesvaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, March 29, 2020
Primary Code005
First Use Anywhere DateThursday, September 8, 2022
First Use In Commerce DateThursday, September 8, 2022

Trademark Owner History

Party NameColorado State University Research Foundation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFort Collins, CO 80526
Party NameColorado State University Research Foundation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFort Collins, CO 80526
Party NameColorado State University Research Foundation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFort Collins, CO 80526

Trademark Events

Event DateEvent Description
Tuesday, November 1, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 1, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, September 27, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, September 26, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 23, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, September 12, 2022USE AMENDMENT FILED
Friday, September 23, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 12, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, March 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 1, 2022SOU EXTENSION 3 GRANTED
Tuesday, March 1, 2022SOU EXTENSION 3 FILED
Tuesday, March 1, 2022TEAS EXTENSION RECEIVED
Thursday, September 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 31, 2021SOU EXTENSION 2 GRANTED
Tuesday, August 31, 2021SOU EXTENSION 2 FILED
Tuesday, August 31, 2021TEAS EXTENSION RECEIVED
Saturday, February 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 11, 2021SOU EXTENSION 1 GRANTED
Thursday, February 11, 2021SOU EXTENSION 1 FILED
Thursday, February 11, 2021TEAS EXTENSION RECEIVED
Tuesday, September 15, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 15, 2020ASSIGNED TO EXAMINER
Sunday, March 29, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 27, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

solavax vaccines